I agree that this site is using cookies. You can find further informations here.
X
Merker, Michael
167  results:
english X
Search for persons X
?
1

Bortezomib promotes the TRAIL-mediated killing of resistant..:

Heim, Catrin ; Hartig, Leonie ; Weinelt, Nadine...
Molecular Therapy: Oncology.  32 (2024)  2 - p. 200802 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Trends and Differences in Status Epilepticus Treatment of C..:

Purwien, Leonore ; Schubert-Bast, Susanne ; Kieslich, Matthias...
CNS Drugs.  37 (2023)  11 - p. 993-1008 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Impact of the First COVID Lockdown on Accident- and Injury-..:

Bruns, Nora ; Willemsen, Lea Y. ; Holtkamp, Katharina...
Children.  9 (2022)  3 - p. 363 , 2022
Link: https://doi.org/10.3390/..
 
?
4

Depletion of CD45RA+ T cells: Advantages and disadvantages ..:

Bremm, Melanie ; Krastel, Theresa ; Cappel, Claudia...
Journal of Immunological Methods.  492 (2021)  - p. 112960 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Retargeting of NK-92 Cells against High-Risk Rhabdomyosarco..:

Gossel, Leonie D. H. ; Heim, Catrin ; Pfeffermann, Lisa-Marie...
Cancers.  13 (2021)  6 - p. 1443 , 2021
Link: https://doi.org/10.3390/..
 
?
6

Superconducting integrated THz receiver 

Karlsruher Schriftenreihe zur Supraleitung ; 28, Hrsg. Prof. Dr.-Ing. M. Noe, Prof. Dr. rer. nat. M. Siegel
Merker, Michael , 2019
Link: https://nbn-resolving.de..
 
?
7

Adoptive cellular immunotherapy for refractory childhood ca..:

Merker, Michael ; Meister, Michael Torsten ; Heinze, Annekathrin...
Oncotarget.  10 (2019)  58 - p. 6138-6151 , 2019
Link: https://doi.org/10.18632..
 
?
8

Clearance of Hematologic Malignancies by Allogeneic Cytokin..:

Merker, Michael ; Salzmann-Manrique, Emilia ; Katzki, Verena...
Biology of Blood and Marrow Transplantation.  25 (2019)  7 - p. 1281-1292 , 2019
Link: https://doi.org/10.1016/..
 
?
9

Haploidentical allogeneic hematopoietic stem cell transplan..:

Merker, Michael ; Meister, Michael Torsten ; Rettinger, Eva...
Bone Marrow Transplantation.  53 (2018)  7 - p. 891-894 , 2018
Link: https://doi.org/10.1038/..
 
?
10

Niobium as Alternative Material for Refractory and Active P..:

Bagheri, Shahin ; Strohfeldt, Nikolai ; Ubl, Monika...
ACS Photonics.  5 (2018)  8 - p. 3298-3304 , 2018
Link: https://doi.org/10.1021/..
 
?
11

AlloHSCT in paediatric ALL and AML in complete remission: i..:

Bakhtiar, Shahrzad ; Salzmann-Manrique, Emilia ; Hutter, Martin...
Bone Marrow Transplantation.  54 (2018)  5 - p. 737-745 , 2018
Link: https://doi.org/10.1038/..
 
?
12

Generation and characterization of ErbB2-CAR-engineered cyt..:

Merker, Michael ; Pfirrmann, Verena ; Oelsner, Sarah...
Oncotarget.  8 (2017)  39 - p. 66137-66153 , 2017
Link: https://doi.org/10.18632..
 
?
13

Pre-Emptive Immunotherapy for Clearance of Molecular Diseas..:

Rettinger, Eva ; Merker, Michael ; Salzmann-Manrique, Emilia...
Biology of Blood and Marrow Transplantation.  23 (2017)  1 - p. 87-95 , 2017
Link: https://doi.org/10.1016/..
 
?
14

Preemptive Treatment of Minimal Residual Disease (MRD) with..:

Bader, Peter ; Huenecke, Sabine ; Bönig, Halvard...
Biology of Blood and Marrow Transplantation.  22 (2016)  3 - p. S43 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Cytomegalovirus-specific cytokine-induced killer cells: con..:

Pfirrmann, Verena ; Oelsner, Sarah ; Rettinger, Eva...
Cytotherapy.  17 (2015)  8 - p. 1139-1151 , 2015
Link: https://doi.org/10.1016/..
 
1-15